TVGN (Tevogen Bio Holdings) Total Long-Term Assets : $1.10 Mil (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Tevogen Bio Holdings's Total Long-Term Assets for the quarter that ended in Dec. 2024 was $1.10 Mil.

Tevogen Bio Holdings Total Long-Term Assets Historical Data

The historical data trend for Tevogen Bio Holdings's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Total Long-Term Assets Chart

Tevogen Bio Holdings Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Total Long-Term Assets

0.49

356.86

3.78

1.10

Tevogen Bio Holdings Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Long-Term Assets	Get a 7-Day Free Trial					3.78	0.96	0.86	0.76	1.10

Tevogen Bio Holdings Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Tevogen Bio Holdings Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (NAS:TVGN) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

G28:Germany

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.